We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXGLW icon
351
NexGel Inc Warrant
NXGLW
$129K ﹤0.01%
550,000
– –
BIVIW
352
BioVie Inc Warrant
BIVIW
$64K
$129K ﹤0.01%
+500,000
New +$164K
ALUR
353
DELISTED
Allurion Technologies
ALUR
$73.7K ﹤0.01%
+59,880
New +$101K
MDCXW
354
Medicus Pharma Warrant
MDCXW
$434K
$48.5K ﹤0.01%
60,600
– –
BJDX icon
355
Bluejay Diagnostics
BJDX
$1.11M
$43.4K ﹤0.01%
+16,250
New +$107K
ONFOW icon
356
Onfolio Holdings Warrant
ONFOW
$64.5K
$34K ﹤0.01%
400,000
– –
LCFYW icon
357
Locafy Ltd Warrant
LCFYW
$26.8K ﹤0.01%
+12,121
New +$64.6K
SWAGW icon
358
Stran & Company Warrant
SWAGW
$66.4K
$21.8K ﹤0.01%
545,000
– –
FGIWW
359
FGI Industries Warrant
FGIWW
$217K
$10K ﹤0.01%
+186,666
New +$13.8K
RVSNW icon
360
Rail Vision Ltd Warrant
RVSNW
$725K
$9.52K ﹤0.01%
136,187
– –
SQFTW icon
361
Presidio Property Trust Inc Series A Warrants
SQFTW
$217K
$6K ﹤0.01%
200,000
– –
IVDAW icon
362
Iveda Solutions Warrant
IVDAW
$47.8K
$2.21K ﹤0.01%
18,125
– –
KTTAW icon
363
Pasithea Therapeutics Warrants
KTTAW
$5.69K
$705 ﹤0.01%
50,000
– –
TNONW icon
364
Tenon Medical Inc Warrant
TNONW
$1.49K
$234 ﹤0.01%
22,250
– –
AES icon
365
AES
AES
$10.5B
– –
-22,592
Closed -$297K
AFRM icon
366
Affirm
AFRM
$25.2B
– –
-17,536
Closed -$1.28M
AGX icon
367
Argan
AGX
$8.37B
– –
-796
Closed -$215K
ALSN icon
368
Allison Transmission
ALSN
$9.82B
– –
-3,059
Closed -$260K
AMT icon
369
American Tower
AMT
$80.4B
– –
-1,444
Closed -$278K
ANET icon
370
Arista Networks
ANET
$238B
– –
-1,720
Closed -$251K
APD icon
371
Air Products & Chemicals
APD
$67.6B
– –
-830
Closed -$226K
ARES icon
372
Ares Management
ARES
$30.9B
– –
-2,044
Closed -$327K
ARMK icon
373
Aramark
ARMK
$14.7B
– –
-5,888
Closed -$226K
AROC icon
374
Archrock
AROC
$5.8B
– –
-88,070
Closed -$2.32M
ASML icon
375
ASML
ASML
$669B
– –
-2,600
Closed -$2.52M
13 14
15
16 17

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.